Delivery Order 36F79721D0249-36C24826F0091
Award Date 2/27/26
Potential Completion Date 3/27/26
Potential Value $147K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- CSL Behring LLC, a global biotherapeutics company specializing in plasma-derived and recombinant therapies, was awarded a delivery order valued at $124,239.92 by Veterans Integrated Service Network 8 (VISN 8) for emergency procurement of HAEGARDA C1 Inhibitor. The contract, awarded on October 22, 2025, with a completion date of November 22, 2025, utilizes firm fixed pricing and carries no set-aside designation. The award is issued under CSL Behring's existing Federal Supply Schedule contract for...
- CSL Behring L.L.C. was awarded a $123,139.52 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8. This firm fixed price order is for the product C1 INHIBITOR to support the agency's medical programs. Performance will take place in King of Prussia, Pennsylvania, with all work completed by December 30, 2022. No set-aside designation was...
- The Department of Veterans Affairs Veterans Health Administration awarded a $167,215.20 firm fixed price delivery order to CSL Behring L.L.C., a foreign-owned for-profit organization, under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The award is to provide the drug C1 Inhibitor, with a completion date of September 30, 2020. This delivery order was issued by Veterans Integrated Service Network 22 to support VA healthcare programs for veterans. CSL Behring is a global...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded CSL Behring L.L.C. a $380,625.84 delivery order under the company's Pharmaceuticals and Drugs (FSS-61-IB) master contract on the General Services Administration (GSA) Multiple Award Schedule. The order is for HAEGARDA C1 INHIBITORS 3000 UNITS to be provided from CSL Behring L.L.C.'s place of performance in King of Prussia, Pennsylvania under firm fixed pricing from October...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $154,935.10 firm fixed price delivery order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration. The contract is for the supply of the Hereditary Angioedema treatment HAEGARDA and the intravenous...
- CSL Behring L.L.C. was awarded a $109,942.20 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7. This delivery order is for the provision of Haegard Pharmaceutical products to support healthcare services for veterans in the King of Prussia, Pennsylvania area through September 30th, 2022. No set-aside designation was applied to this...
- The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., doing business as CSL Behring LLC, a global biotherapeutics company. The $208,978.20 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration. The contract is to provide the Hereditary Angioedema treatment medication HAEGARDA to VA medical...
- CSL Behring L.L.C. was awarded a $58,635.84 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The firm fixed price order is for the delivery of HAEGARDA vials to the place of performance in King of Prussia, Pennsylvania, with completion scheduled for June 19, 2022. No set-aside designation was applied to this order, which was awarded on June 14, 2022...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a firm fixed price delivery order to CSL Behring L.L.C. under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The $132,404.92 award was made for the supply of HIZENTRA and HAEGARDA pharmaceutical products to VA medical facilities. CSL Behring, a global biotherapeutics company, has provided specialty drugs such as HAEGARDA for the treatment of hereditary...